US Patent Issued to NEUROVALENS on Dec. 30 for "Systems, devices and methods for treating post-infection symptoms of COVID-19 using vestibular nerve stimulation" (California, Massachusetts Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,419, issued on Dec. 30, was assigned to NEUROVALENS Ltd. (Portglenone, Great Britain).

"Systems, devices and methods for treating post-infection symptoms of COVID-19 using vestibular nerve stimulation" was invented by Jason McKeown (Boston) and Paul Duncan McGeoch (Stanford, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods, systems and devices are provided to stimulate the vestibular system in such a way as to alleviate post-infection symptoms of COVID-19. A device with one or more electrodes placed over a subject's scalp provides vestibular nerve stimulation (VeNS) to the vestibular nerve, which is then carried into the vestibular nucl...